Patents Assigned to SERRATA LLC
  • RISK ANALYSIS FOR DISEASE DEVELOPMENT
    Publication number: 20140134630
    Abstract: In certain embodiments, a novel means for identifying the onset or change in level of severity of given disease states, and/or identifying a patient's risk for experiencing the onset or change in level of severity of given disease states is provided. In some embodiments, a predictive model is provided, which can be used to predict an individual's propensity for developing a given disease or for advancing to a certain stage of a given disease.
    Type: Application
    Filed: April 4, 2012
    Publication date: May 15, 2014
    Applicant: Serrata, LLC
    Inventor: Sai Chavala
  • MDM2 INHIBITORS FOR TREATMENT OF OCULAR CONDITIONS
    Publication number: 20130225603
    Abstract: Provided herein are pharmaceutical compositions for the treatment of various ocular diseases characterized by unwanted cellular proliferation. The pharmaceutical compositions may comprise one or more MDM2 inhibitors, and may further comprise one or more additional therapeutic agents. Also provided are methods of use of MDM2 inhibitors and/or formulations thereof for the treatment of ocular diseases characterized by unwanted cellular proliferation.
    Type: Application
    Filed: September 26, 2011
    Publication date: August 29, 2013
    Applicant: SERRATA LLC
    Inventors: Sai Chavala, Thomas Cramer Lee